Quell offers drug-free pain relief

WALTHAM, Mass. — NeuroMetrix is aiming its wearable pain relief device Quell at a customer it believes is underserved. “Today, in terms of a serious therapeutic wearable device for chronic pain, we’re pretty unique,” NeuroMetrix SVP and general manager of consumer health Frank McGillin said. “There’s been an adoption of fitness trackers ... and obviously rapid growth of those primarily around the ‘worried well’ — they’re either active people trying to be even more active or they’re focused on their health. But there’s this large population of Americans suffering from chronic disease, and current devices aren’t addressing what their needs are.”

(Click here to view the full Category Review.)



In clinical trials, about two-thirds of participants reduced their medication use when using Quell, McGillin said. According to McGillin, $50 billion a year is spent on the treatment of chronic pain, “yet [more than] half the people are saying their pain isn’t adequately controlled.”